Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian CancerInvestors Business Daily • 04/05/23
Compass Group and AstraZeneca Expand Activities Focused on Innovation and Shared SuccessBusiness Wire • 03/29/23
3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030The Motley Fool • 03/23/23
Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV RaceInvestors Business Daily • 03/08/23
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease AssayBusiness Wire • 03/07/23
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901PRNewsWire • 02/23/23
AstraZeneca and Merck present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers SymposiumBusiness Wire • 02/16/23